Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 
Asian Markets Surge as Japan Election, Fed Rate Cut Bets, and Tech Rally Lift Global Sentiment 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran 
Oil Prices Slip as U.S.-Iran Talks Ease Middle East Tensions 
UK Starting Salaries See Strongest Growth in 18 Months as Hiring Sentiment Improves 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
GSK Consumer Healthcare Korea was revealed to have appointed a new chief executive officer, and it was revealed to be Shin Dong Woo, a former CEO of the company’s branch in Hong Kong.
According to The Korea Times, GSK Consumer Healthcare Korea announced the assignment of CEO Shin earlier this week. It was reported that the new chief has been with the company for 28 years and has led GSK in various international businesses - from consumer health care to general consumer goods.
He also led other health care firms such as Pfizer and Sanofi. Prior to his assignment as the new chief at GSK Consumer Healthcare Korea, he has been leading the Honk Kong unit for the last two years. During his tenure, he has many achievements, including boosting the business and building the foundation for its stability.
At Sanofi Korea, he became the first president of the He also completed the company's integration with Pfizer Consumer Healthcare, where he was CEO of the Korean branch and the Asia-Pacific region between 2015 and 2020.
Shin also became the very first president of the French multinational healthcare company’s Korean unit. He helped established the brand in the country and introduced major products that are now selling very well here., and this is not all. Shin has extensive experience in marketing as well as he worked at Coca-Cola, L’Oreal, and Fox Home Entertainment and was in charge of marketing and sales for more than a decade.
Meanwhile, Shin will lead GSK Consumer Healthcare Korea, which has recently changed its name to Haleon. This will be the company’s official name as it starts its consumer healthcare venture. The name means the company will also change all of its product packaging.
"With the announcement of 'Haleon' today, we are one step closer to our goal of becoming a consumer healthcare company,” Haleon’s CEO-nominee, Brian McNamara, said in a press release in February. “'Haleon' will stand as a leader in the consumer healthcare industry with the vision of delivering better daily health to mankind.”
“Haleon” is the outcome of the successful merging of Novartis in 2015 and Pfizer's consumer healthcare portfolio in 2019 over the past eight years.
